Two expert-led podcasts with highlights from ASCO’s Annual Meeting. These podcasts cover research on prostate cancer, bladder cancer, and melanoma.
You probably heard a lot of research buzz during ASCO’s recent Annual Meeting. But as the dust settles, we’ll continue to highlight some of the important research that was presented at the meeting. Over the next several weeks, the Research Round Up podcast series will feature top cancer experts explaining what this research means for patients.
High temperatures can cause issues for people receiving cancer treatment. Get some tips on staying cool and hydrated this summer.
In this podcast, two oncology pharmacists share about their role on the cancer care team. Hear from experts R. Donald Harvey, PharmD, FCCP, BCOP and John Valgus, PharmD, BCOP, CPP.
Research Highlights on Immunotherapy for Melanoma and Cervical Cancer From the 2014 ASCO Annual Meeting
Activating and amplifying the body’s immune response to cancer is an exciting area of research. See how it is being used to better treat advanced or high-risk melanoma and cervical cancer in these four studies presented in Chicago today.
Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.
New Strategies to Improve Quality of Life for Patients, Survivors, and Caregivers From the 2014 ASCO Annual Meeting
Researchers are continuing to find new ways to reduce the side effects of treatment and improve quality of life. Get highlights of five studies presented today at the ASCO Annual Meeting.
In this podcast, you’ll learn about key definitions and categories of cancer research studies. It also has tips for finding medical journals.
Get highlights of five studies showing promise in novel targeted therapies, cancer prevention, and patient care that will be presented at ASCO’s 50th Annual Meeting.